DNA Methyltransferase Inhibitor

DNA Methyltransferase Inhibitors (38):

Cat. No.	Product Name	Effect	Purity

HY-139664

GSK-3685032	Inhibitor	99.95%
GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC₅₀ of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition.

HY-13765

6-Thioguanine	Inhibitor	98.01%
6-Thioguanine (Thioguanine; 2-Amino-6-purinethiol) is an anti-leukemia and immunosuppressant agent, acts as an inhibitor of SARS and MERS coronavirus papain-like proteases (PLpros) and also potently inhibits USP2 activity, with IC₅₀s of 25 μM and 40 μM for Plpros and recombinant human USP2, respectively.

HY-A0084A

Procainamide	Inhibitor	99.69%
Procainamide (Procaine amide) is a specific and potent inhibitor of DNA methyltransferase 1 (DNMT1), which reactivates the expression of tumor suppressor factors by demethylating tumor suppressor genes. Procainamide induces vacuolization in various cell types and reduces cell proliferation and migration. Procainamide relaxes airway smooth muscle by activating potassium channels. Procainamide can be used in cancer and arrhythmia research.

HY-B0106

Levetiracetam	Inhibitor	99.90%
Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent.

HY-117421A

CM-579 trihydrochloride	Inhibitor
CM-579 trihydrochloride is a first-in-class reversible, dual inhibitor of G9a and DNMT, with IC₅₀ values of 16 nM, 32 nM for G9a and DNMT, respectively. Has potent in vitro cellular activity in a wide range of cancer cells.

HY-13542

Guadecitabine	Inhibitor	98.0%
Guadecitabine (SGI-110) is a second-generation DNA methyltransferases (DNMT) inhibitor for research of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).

HY-A0084

Procainamide hydrochloride	Inhibitor	≥98.0%
Procainamide hydrochloride (Procaine amide hydrochloride) is a specific and potent inhibitor of DNA methyltransferase 1 (DNMT1), which reactivates the expression of tumor suppressor factors by demethylating tumor suppressor genes. Procainamide hydrochloride induces vacuolization in various cell types and reduces cell proliferation and migration. Procainamide hydrochloride relaxes airway smooth muscle by activating potassium channels. Procainamide hydrochloride can be used in cancer and arrhythmia research.

HY-161402

METTL16-IN-1	Inhibitor	99.22%
METTL16-IN-1 (Compound 45) is a potent METTL16 inhibitor with an IC₅₀ value of 1.7 μM and a K_d value of 1.35 μM. METTL16-IN-1 has antitumor activity.

HY-162082

METTL1-WDR4-IN-2	Inhibitor	99.71%
METTL1-WDR4-IN-2 (compound 6) is a selective methyltransferase Like 1 (METTL1)-WDR4 inhibitor with an IC₅₀ of 41 μM. METTL1-WDR4-IN-2 shows remarkable selectivity against METTL3-14 and slightly selective also against METTL16.

HY-N2150

Psammaplin A	Inhibitor
Psammaplin A, a marine metabolite, is a potent inhibitor of HDAC and DNA methyltransferases. Psammaplin A ia a highly potent and selective DAC1 inhibitor with an IC₅₀ of 0.9 nM. Psammaplin A possess the antimicrobial effect on the Gram-positive bacteria and inhibits DNA synthesis and DNA gyrase activity. Antitumor Activity.

HY-150249

GSK3735967	Inhibitor	99.71%
GSK3735967 is an selective, reversible, non-nucleoside inhibitor of DNMT1 with an IC₅₀ value of 40 nM. GSK3735967 contains a planar dicyanopyridine core that can specifically embed DNMT1 bound hemimethylated CpG dinucleotides. GSK3735967 has three binding sites, one of which can bind to histone H4K20me3.

HY-131991

Benzyl selenocyanate	Inhibitor	≥99.0%
Benzyl selenocyanate is a chemopreventive agent for various chemically induced tumors in animal models at both the initiation and postinitiation stages. Benzyl selenocyanate is an inhibitor of DNA (cytosine-5)-methyltransferase (Mtase), with an with an IC₅₀ of 8.4 µM.

HY-12310

RSC133	Inhibitor	≥98.0%
RSC133 exhibits dual activity by inhibiting histone deacetylase and DNA methyltransferase. RSC133 effectively facilitates reprogramming of human somatic cells to pluripotent stem cells and supports the maintenance of an undifferentiated state of human pluripotent stem cells.

HY-123346

SW155246	Inhibitor	98.31%
SW155246 is a DNA methyltransferase (DNMT1) selective inhibitor with IC₅₀s of 1.2 and 38 μM for hDNMT1 and mDNMT3A, respectively. SW155246 can be used for the research of cancer and other diseases.

HY-117421

CM-579	Inhibitor
CM-579 is a first-in-class reversible, dual inhibitor of G9a and DNMT, with IC₅₀ values of 16 nM, 32 nM for G9a and DNMT, respectively. Has potent in vitro cellular activity in a wide range of cancer cells.

HY-A0004R

Decitabine (Standard)	Inhibitor
Decitabine (Standard) is the analytical standard of Decitabine. This product is intended for research and analytical applications. Decitabine (NSC 127716) is an orally active deoxycytidine analogue antimetabolite and a DNA methyltransferase inhibitor. Decitabine incorporates into DNA in place of cytosine can covalently trap DNA methyltransferase to DNA causing irreversible inhibition of the enzyme. Decitabine induces cell G2/M arrest and cell apoptosis. Decitabine has potent anticancer activity.

HY-111644

6-Methyl-5-azacytidine	Inhibitor
6-Methyl-5-azacytidine is a potent DNMT inhibitor.

HY-119390

AA-CW236	Inhibitor	99.86%
AA-CW236 is a MGMT (O6-methylguanine DNA methyltransferase) inhibitor. AA-CW236 targets MGMT active site Cys145 for covalent modification.

HY-133030

DNMT-IN-1	Inhibitor
DNMT-IN-1 is a potent DNMT inhibitor with an EC₅₀ value of 3.2 µM. DNMT-IN-1 shows antiproliferative active.

HY-163614

SARS-CoV-2-IN-87	Inhibitor
SARS-CoV-2-IN-87 (compound 138968421) is a potent inhibitor of methyltransferases (nsp14 and nsp16) of SARS-CoV-2.

Name
Email *

	Sorry, but the email address you supplied was invalid.